• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物-赋形剂相容性研究在原诺体制剂中:以白藜芦醇为例。

Drug-Excipients Compatibility Studies in Proniosomal Formulation: A Case Study with Resveratrol.

机构信息

Department of Life and Environmental Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

Department of Pharmaceutical Science, University of Milan, Via Venezian 21, 20133, Milan, Italy.

出版信息

J Nanosci Nanotechnol. 2021 May 1;21(5):2917-2921. doi: 10.1166/jnn.2021.19056.

DOI:10.1166/jnn.2021.19056
PMID:33653458
Abstract

Proniosomal drug delivery system is one of the advancements in nanotechnology. Similarly to traditional dosage forms, chemical and physical compatibility of proniosomes components with the active ingredient(s) is a key step in the preformulation process of such systems. In this work, the compatibility of resveratrol with selected excipients in the development of proniosomal formulation was investigated by thermal and spectroscopic techniques. To evaluate the drug-excipient compatibility, different techniques such as differential scanning calorimetric study, attenuated total reflectance Fourier transform infrared spectroscopy study and powder X-ray diffraction were adopted. The results showed that the excipients used in the formulation were compatible with resveratrol.

摘要

前体药物传递系统是纳米技术的一项进展。与传统剂型类似,前体药物系统的制剂前工艺的关键步骤是前体药物成分与活性成分(s)的化学和物理相容性。在这项工作中,通过热和光谱技术研究了白藜芦醇与前体药物制剂开发中所选赋形剂的相容性。为了评估药物-赋形剂的相容性,采用了不同的技术,如差示扫描量热法研究、衰减全反射傅里叶变换红外光谱研究和粉末 X 射线衍射。结果表明,配方中使用的赋形剂与白藜芦醇相容。

相似文献

1
Drug-Excipients Compatibility Studies in Proniosomal Formulation: A Case Study with Resveratrol.药物-赋形剂相容性研究在原诺体制剂中:以白藜芦醇为例。
J Nanosci Nanotechnol. 2021 May 1;21(5):2917-2921. doi: 10.1166/jnn.2021.19056.
2
Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques.采用热分析、光谱和色谱技术对恩格列净与固体制剂中选用的药用辅料的相容性评估进行更新。
Drug Dev Ind Pharm. 2020 Feb;46(2):209-218. doi: 10.1080/03639045.2020.1716371. Epub 2020 Jan 22.
3
Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.使用热法和非热法进行卡马西平与片剂辅料的相容性研究。
Drug Dev Ind Pharm. 2002 Jul;28(6):687-94. doi: 10.1081/ddc-120003860.
4
Compatibility studies of nateglinide with excipients in immediate release tablets.那格列奈与速释片辅料的相容性研究。
Acta Pharm. 2011 Jun;61(2):237-47. doi: 10.2478/v10007-011-0016-4.
5
FTIR and TG analyses coupled with factor analysis in a compatibility study of acetazolamide with excipients.傅里叶变换红外光谱和热重分析结合因子分析研究乙酰唑胺与赋形剂的相容性。
Spectrochim Acta A Mol Biomol Spectrosc. 2019 Feb 5;208:285-293. doi: 10.1016/j.saa.2018.10.020. Epub 2018 Oct 13.
6
FTIR, Raman spectroscopy and HT-XRD in compatibility study between naproxen and excipients.傅里叶变换红外光谱、拉曼光谱和高压 X 射线衍射在萘普生与辅料相容性研究中的应用。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Dec 5;302:123048. doi: 10.1016/j.saa.2023.123048. Epub 2023 Jun 20.
7
Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.采用热法和非热法对盐酸异丙嗪与片剂辅料进行相容性研究。
Pharmazie. 2009 Mar;64(3):183-9.
8
Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.采用X射线粉末衍射、差示扫描量热法和衰减全反射傅里叶变换红外光谱法对原料药和片剂制剂中甲磺酸伊马替尼的两种多晶型进行定量测定。
J Pharm Biomed Anal. 2015 Oct 10;114:330-40. doi: 10.1016/j.jpba.2015.06.011. Epub 2015 Jun 12.
9
Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.评估盐酸格拉司琼与片剂辅料相容性的热法和非热法
Pharmazie. 2008 Jun;63(6):453-8.
10
Assessing the Compatibility of Menatetrenone with Excipients: A Spectroscopic Approach and Implication in Drug Formulation Development.评估维生素K4与辅料的相容性:一种光谱学方法及其在药物制剂开发中的意义。
Drug Res (Stuttg). 2024 Sep;74(7):347-359. doi: 10.1055/a-2361-2895. Epub 2024 Aug 2.

引用本文的文献

1
Development of the novel formulations of perospirone for the treatment of schizophrenia.用于治疗精神分裂症的哌罗匹隆新型制剂的研发。
Drug Deliv Transl Res. 2025 Jun;15(6):2162-2178. doi: 10.1007/s13346-024-01730-7. Epub 2024 Oct 31.